| Literature DB >> 26271893 |
Marjorie De la Fuente1, Thomas T MacDonald2, Marcela A Hermoso3.
Abstract
IL-33, an IL-1 family member, is expressed by many cell types and can regulate gene transcription. IL-33 is released upon cell necrosis and the precursor form is enzymatically processed, and then drives inflammation as a damage-associated molecular pattern. The IL-33 receptor ST2, encoded by IL1RL1, is expressed as both a membrane-anchored receptor (ST2L) activated by IL-33, and as a soluble variant (sST2) that exhibits anti-inflammatory properties. The IL-33/ST2 axis is involved in the pathogenesis of atopic and autoimmune diseases, cancer, and central nervous system disorders. Here, we review recent findings on the role of the IL-33/ST2 axis in health and disease.Entities:
Keywords: Autoimmunity; IL-33; Inflammatory bowel diseases; ST2; Table of contents
Mesh:
Substances:
Year: 2015 PMID: 26271893 DOI: 10.1016/j.cytogfr.2015.07.017
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638